Infectious Disease Puscast
Infectious Disease Puscast #46
Jan 24, 2024 · 36 min · Episode 46 · 26.8 MB
0:00-36:49
Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
On episode #46 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 1/4 – 1/17/24.
Hosts: Daniel Griffin and Sara Dong
Subscribe (free): Apple Podcasts, RSS, email
Become a patron of Puscast!
Links for this episode- Comparing the performance of three models incorporating weather data to forecast dengue epidemics (JID)
- Elucidating the impacts of climate on dengue transmission through mathematical models (JID)
- Infants receiving a single dose of nirsevimab to prevent RSV do not have evidence of enhanced disease in their second RSV season (JPIDS)
- Patient perspectives on solid organ transplantation from donors with hepatitis C viremia to recipients without hepatitis C viremia (OFID)
- Oral Beta-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for definitive treatment of uncomplicated Escherichia coli or Klebsiella species bacteremia from a urinary source (OFID)
- Discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus in a pediatric healthcare system (JPIDS)
- Oral linezolid compared with benzathine PCN G for treatment of early syphilis in adults (The Lancet)
- Model-informed precision dosing improves outcomes in patients receiving vancomycin for gram-positive infections (OFID)
- The Xpert MTB/RIF cycle threshold value predicts M.tuberculosis transmission to close contacts (CID)
- Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (The Lancet)
- Oral antibiotics for treatment of Gram negative bacteremia in solid organ transplant recipients (CID)
- Dematiaceous fungal keratitis with tentacles mimicking Pythium Keratitis (Jama)
- Verification, analytical sensitivity, cost-effectiveness, and comparison of four Candida auris screening methods (OFID)
- Tafenoquine-Atovaquone combination achieves radical cure and confers sterile immunity in experimental models of human babesiosis (JID)
- Relapsing babesiosis with molecular evidence of resistance to certain antimicrobials commonly used to treat Babesia microti infections (OFID)
- Understanding parental leave policies in ID fellowship (OFID)
- What's hot this year in ID clinical science (CID)
Music is by Ronald Jenkees
Daniel Griffin
parasiteswithoutborders.comSara Dong
twitter.comApple Podcasts
podcasts.apple.comRSS
feeds.libsyn.compatron
microbe.tvComparing
academic.oup.comimpacts of climate
academic.oup.comevidence of enhanced disease
academic.oup.comhepatitis C viremia
academic.oup.commethicillin-resistant Staphylococcus aureus
academic.oup.comOral linezolid
thelancet.comimproves outcomes
academic.oup.comXpert MTB/RIF cycle threshold value
academic.oup.comEnterobacterales
thelancet.comOral antibiotics
academic.oup.comPythium Keratitis
edhub.ama-assn.orgCandida auris screening methods
academic.oup.comTafenoquine-Atovaquone
academic.oup.comBabesia microti
academic.oup.comparental leave policies
academic.oup.comWhat's hot
academic.oup.comRonald Jenkees
ronaldjenkees.com